{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-108359","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.611054+00:00","generated_at":"2026-06-10T02:41:58.747417+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Orchestra BioMed postpones Virtue SAB pivotal study to 2024 amid Terumo negotiations","bullets":["Filed registration statement for resale of shares/warrants; not seeking additional capital.","Negotiating with Terumo to restructure milestone payments and modify distribution agreement.","Virtue ISR-US pivotal study initiation postponed to 2024 due to ongoing negotiations.","If negotiations not satisfactory, clinical/commercial plans for Virtue SAB may be further affected."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-108359","json":"https://secwatch.observer/filing/0001104659-23-108359.json","markdown":"https://secwatch.observer/filing/0001104659-23-108359.md","text":"https://secwatch.observer/filing/0001104659-23-108359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923108359/0001104659-23-108359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923108359/tm2328162d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:41:58.747417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}